Why should you consider investing in cancer-fighting stocks? Probably for the same reason you would consider investing in any kind of stock: the potential to generate attractive, market-beating, long-term gains.
The IQVIA Institute for Human Data Science projects that spending on cancer therapies will soar to as much as $250 billion by 2023, up from $150 billion in 2018. This presents a significant opportunity for investors who buy the right stocks. But it’s first important to… Continue reading at Fool.com